296 related articles for article (PubMed ID: 17283484)
1. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.
Itakura S; Asari S; Rawson J; Ito T; Todorov I; Liu CP; Sasaki N; Kandeel F; Mullen Y
Am J Transplant; 2007 Feb; 7(2):336-46. PubMed ID: 17283484
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells facilitate mixed hematopoietic chimerism induction and prevent onset of diabetes in nonobese diabetic mice.
Asari S; Itakura S; Rawson J; Ito T; Todorov I; Nair I; Shintaku J; Liu CP; Kandeel F; Mullen YS
Pancreas; 2011 Aug; 40(6):846-54. PubMed ID: 21562444
[TBL] [Abstract][Full Text] [Related]
4. Indefinite survival of rat islet allografts following infusion of donor bone marrow without cytoablation.
Ricordi C; Murase N; Rastellini C; Behboo R; Demetris AJ; Starzl TE
Cell Transplant; 1996; 5(1):53-5. PubMed ID: 8665077
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of an iNKT cell ligand and CD40-CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients.
Kanzawa T; Hirai T; Fukuda H; Katsumata H; Ishii R; Ikemiyagi M; Ishii Y; Saiga K; Okumi M; Tanabe K
Acta Diabetol; 2019 May; 56(5):541-550. PubMed ID: 30758788
[TBL] [Abstract][Full Text] [Related]
6. Induction of stable chimerism and transplantation tolerance to rat islet and heart allografts by ultraviolet-B modulation of bone marrow cells.
Jin MX; Engelstad K; Oluwole SF
Transplantation; 1992 Jul; 54(1):113-8. PubMed ID: 1385914
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice.
Seung E; Iwakoshi N; Woda BA; Markees TG; Mordes JP; Rossini AA; Greiner DL
Blood; 2000 Mar; 95(6):2175-82. PubMed ID: 10706892
[TBL] [Abstract][Full Text] [Related]
8. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.
Li H; Colson YL; Ildstad ST
Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945
[TBL] [Abstract][Full Text] [Related]
9. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?
Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T
Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502
[TBL] [Abstract][Full Text] [Related]
10. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
Fiedor P; Jin MX; Hardy MA; Oluwole SF
Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
[TBL] [Abstract][Full Text] [Related]
11. Tolerance induction permits the development of graft-versus-host disease: donor-mediated attack following small bowel transplantation in mixed chimeras.
Morrissey NJ; Blom D; Ryan CK; Fisher T; Bronsther O; Orloff MS
Transpl Immunol; 1999 Mar; 7(1):19-25. PubMed ID: 10375074
[TBL] [Abstract][Full Text] [Related]
12. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.
Lin JY; Tsai FC; Wallace CG; Huang WC; Wei FC; Liao SK
J Surg Res; 2012 Nov; 178(1):487-93. PubMed ID: 22484382
[TBL] [Abstract][Full Text] [Related]
13. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts.
Li H; Inverardi L; Molano RD; Pileggi A; Ricordi C
Transplantation; 2003 Apr; 75(7):966-70. PubMed ID: 12698081
[TBL] [Abstract][Full Text] [Related]
14. Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation.
Pathak S; Meyer EH
Front Immunol; 2020; 11():612737. PubMed ID: 33658995
[TBL] [Abstract][Full Text] [Related]
15. Kidney Versus Islet Allograft Survival After Induction of Mixed Chimerism With Combined Donor Bone Marrow Transplantation.
Oura T; Ko DS; Boskovic S; O'Neil JJ; Chipashvili V; Koulmanda M; Hotta K; Kawai K; Nadazdin O; Smith RN; Cosimi AB; Kawai T
Cell Transplant; 2016; 25(7):1331-41. PubMed ID: 26337731
[TBL] [Abstract][Full Text] [Related]
16. A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment.
Neipp M; Gammie JS; Exner BG; Li S; Chambers WH; Pham SM; Ildstad ST
Transplantation; 1999 Aug; 68(3):369-78. PubMed ID: 10459540
[TBL] [Abstract][Full Text] [Related]
17. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Sachs DH; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
[TBL] [Abstract][Full Text] [Related]
18. The importance of MHC class II in allogeneic bone marrow transplantation and chimerism-based solid organ tolerance in a rat model.
Timrott K; Beetz O; Oldhafer F; Klempnauer J; Vondran FWR; Jäger MD
PLoS One; 2020; 15(5):e0233497. PubMed ID: 32442182
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
[TBL] [Abstract][Full Text] [Related]
20. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
Colson YL; Zadach K; Nalesnik M; Ildstad ST
Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
